Response Surface Methodology as a Tool for Stability-Indicating Method Development and Validation for the Determination of Selective EZH2 Inhibitor

ABSTRACT

Background: Tazemetostat (TZST) is an efficient first-in-class, selective, EZH2 oral inhibitor which had demonstrated tumor regression and favourable safety in patients with Epithelioid Sarcoma. Methods developed using Analytical Quality by Design (AQbD) are highly robust, cost effective, uses good experimental designs, have shorter run times, optimization can be done by statistical analysis and can be easily validated. Objectives: The objective of the present study was to use the Screening designs for selection of initial chromatographic conditions and Response Surface Methodology (RSM) for development of optimized method based on desirability functions approach and validate sthe developed method as per ICH guidelines. Materials and Methods: To select the column, organic modifier and buffer, a 23 Factorial design was used initially for the experimental plans which majorly affect selectivity. Optimization of the method was done using Central Composite Design (CCD) under RSM Results: Design-Expert software was used for statistical analysis of responses from CCD experimental data using ANOVA and multiple regression analysis. The set of CMP’s which shows a maximum composite desirability was taken as optimized chromatographic conditions and evaluated for the responses. Conclusion: The present work successfully demonstrated the use of AQbD approach for developing and validating stability-indicating RP-HPLC method for determination of TZST

KEYWORDS

• TZST
• AQbD
• CCD
• RSM
• Stability-indicating

Showing references and in-text citations exactly as published.

• DOI10.5530/ijper.20254323Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPER.

• Article · VOLUME 59, ISSUE 2SA Qualitative Study on Lecture Capturing System in Pharmacy Education-Learners’ PerspectiveSaranraj Loganathan, Rajkumaran Soundarraj, Vishwalingam Murugan Sujetha · pp. s410–s413Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2SFormulation and Evaluation of Simvastatin Loaded Nanostructured Lipid Carrier for Topical Drug DeliveryMadhuri Desai, Shalaka Dhanna, Sujata Jadhav, Akshada Koparde, Akansha Dashwanat, Rutuja Gharal · pp. s414–s425Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2SOptimized Vildagliptin Microsphere Formulation and in vitro Characterization Using 23 Factorial Design AnalysisSundaramoorthi Revathi, Pavadai Anitha, Sathappan Jenifer, Sivakumar Senthil Rajan · pp. s426–s435Original ArticleSame type: Article
• Article · VOLUME 59, ISSUE 2SBilosome Nanocarriers for Enhanced Oral Bioavailability and Cardiovascular Activity of MilrinoneKiruthika Santhinathan, Susmitha Durai, Rijivana Sirajudeen, Gopinath Govindhraji, Saravanan Gopal, Gayathri Kumararaja · pp. s436–s442Original ArticleSame type: Article